[
  {
    "date": "2023-12-30",
    "symbol": "CERE",
    "period": "FY",
    "entityregistrantname": "CEREVEL THERAPEUTICS HOLDINGS, INC.",
    "entitycentralindexkey": 1805387,
    "amendmentflag": "false",
    "currentfiscalyearenddate": "--12-31",
    "documenttype": "10-K",
    "documentperiodenddate": "2023-12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "entitywellknownseasonedissuer": "Yes",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityfilercategory": "Large Accelerated Filer",
    "entityshellcompany": "false",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "false",
    "icfrauditorattestationflag": "true",
    "documentfinstmterrorcorrectionflag": "false",
    "entityfilenumber": "001-39311",
    "entitytaxidentificationnumber": "85-3911080",
    "entityaddressaddressline1": "222 Jacobs Street",
    "entityaddressaddressline2": "Suite 200",
    "entityaddresscityortown": "Cambridge",
    "entityaddressstateorprovince": "MA",
    "entityaddresspostalzipcode": 2141,
    "cityareacode": 844,
    "localphonenumber": "304-2048",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "Common stock, par value $0.0001 per share",
    "tradingsymbol": "CERE",
    "securityexchangename": "NASDAQ",
    "entityincorporationstatecountrycode": "DE",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "auditorname": "Ernst & Young LLP",
    "auditorlocation": "Boston, Massachusetts",
    "auditorfirmid": 42,
    "cashandcashequivalentsatcarryingvalue": 416465000,
    "availableforsalesecuritiesdebtsecuritiescurrent": 574500000,
    "prepaidexpenseandotherassetscurrent": 15973000,
    "assetscurrent": 1006938000,
    "availableforsalesecuritiesdebtsecuritiesnoncurrent": 185199000,
    "propertyplantandequipmentnet": 25647000,
    "operatingleaserightofuseasset": 20125000,
    "restrictedcashandcashequivalentsnoncurrent": 1960000,
    "otherassetsnoncurrent": 3429000,
    "assets": 1243298000,
    "accountspayablecurrent": 11863000,
    "accruedliabilitiesandotherliabilities": 76912000,
    "operatingleaseliabilitycurrent": 3404000,
    "liabilitiescurrent": 92179000,
    "operatingleaseliabilitynoncurrent": 27786000,
    "noncurrentfinancingliabilityrelatedparty": 56082000,
    "noncurrentfinancingliability": 56082000,
    "convertibledebtnoncurrent": 337424000,
    "liabilities": 569553000,
    "commonstockvalue": 18000,
    "additionalpaidincapital": 2072553000,
    "accumulatedothercomprehensiveincomelossnetoftax": 1771000,
    "retainedearningsaccumulateddeficit": -1400597000,
    "stockholdersequity": 673745000,
    "liabilitiesandstockholdersequity": 1243298000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 500000000,
    "commonstocksharesissued": 181362064,
    "commonstocksharesoutstanding": 181362064,
    "researchanddevelopmentexpense": 334641000,
    "generalandadministrativeexpense": 112624000,
    "operatingexpenses": 447265000,
    "operatingincomeloss": -447265000,
    "investmentincomeinterest": 43865000,
    "interestexpense": 10567000,
    "othernonoperatingincomeexpense": -18372000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -432339000,
    "incometaxexpensebenefit": 503000,
    "netincomeloss": -432842000,
    "earningspersharebasic": -2.67,
    "earningspersharediluted": -2.67,
    "weightedaveragenumberofsharesoutstandingbasic": 162056405,
    "weightedaveragenumberofdilutedsharesoutstanding": 162056405,
    "othercomprehensiveincomelossfinancialliabilityfairvalueoptionunrealizedgainlossarisingduringperiodaftertax": -5220000,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": 3894000,
    "othercomprehensiveincomelossnetoftax": -1326000,
    "comprehensiveincomenetoftax": -434168000,
    "sharesoutstanding": 181362064,
    "stockissuedduringperiodvaluenewissues": 2000,
    "stockissuedduringperiodsharesnewissues": 22687417,
    "stockissuedduringperiodsharessharebasedcompensation": 305375,
    "stockissuedduringperiodvaluestockoptionsexercised": 16493000,
    "stockissuedduringperiodsharesstockoptionsexercised": 1788964,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 2068000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 78023,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 69410000,
    "profitloss": -432842000,
    "depreciationdepletionandamortization": 5627000,
    "adjustmentstooperatingleaseexpense": 1189000,
    "sharebasedcompensation": 69410000,
    "changeinfairvalueoffinancingliability": 18346000,
    "amortizationoffinancingcosts": 1942000,
    "accretionamortizationofdiscountsandpremiumsinvestments": 19700000,
    "othernoncashincomeexpense": 8000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 1993000,
    "increasedecreaseinotheroperatingassets": 1343000,
    "increasedecreaseinaccountspayable": 2038000,
    "increasedecreaseinaccruedliabilities": 17411000,
    "netcashprovidedbyusedinoperatingactivities": -342301000,
    "paymentstoacquiremarketablesecurities": 865270000,
    "proceedsfromsaleandmaturityofmarketablesecurities": 942800000,
    "paymentstoacquirepropertyplantandequipment": 3808000,
    "netcashprovidedbyusedininvestingactivities": 73722000,
    "proceedsfromissuanceofcommonstock": 498944000,
    "proceedsfromissuanceofsharesunderincentiveandsharebasedcompensationplansincludingstockoptions": 18561000,
    "proceedsfromrelatedpartydebt": 15625000,
    "proceedsfromrepaymentsofotherlongtermdebt": 15625000,
    "paymentsoffinancingcosts": 139000,
    "netcashprovidedbyusedinfinancingactivities": 548616000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": 280037000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 418425000,
    "interestpaidnet": 8601000,
    "incometaxespaidnet": 614000,
    "offeringcostsincludedinaccountspayableandothercurrentliabilities": 75000,
    "reclassificationofdeferredfinancingcoststoadditionalpaidincapital": 165000,
    "businesscombinationexchangeratiodescription": "The shares and corresponding capital amounts and loss per share related to Old Cerevelâ€™s outstanding redeemable convertible preferred stock, redeemable convertible common stock and common stock prior to the Business Combination Transaction have been retroactively restated to give effect to the exchange ratio established in the Business Combination Agreement (1.00 Old Cerevel share for 2.854 shares of New Cerevel), or the Exchange Ratio.",
    "stockexchangeratio": 2.854,
    "proceedsfromissuanceorsaleofequity": 350000000,
    "decreaseinaccumulateddeficit": 3900000,
    "numberofoperatingsegments": 1,
    "numberofreportablesegments": 1,
    "revenuefromcontractwithcustomerexcludingassessedtax": 500000000,
    "increasedecreaseinresearchanddevelopmentexpense": 3100000,
    "researchanddevelopmentqualifyingcostsreimbursementreceivable": 600000,
    "restrictedcash": 1960000,
    "propertyplantandequipmentusefullife": "P3Y",
    "propertyplantandequipmentusefullifedescriptionoftermextensibleenumeration": "http://fasb.org/us-gaap/2023#UsefulLifeShorterOfTermOfLeaseOrAssetUtilityMember",
    "regulatoryapprovalmilestonepayments": 7500000,
    "aggregateamountofregulatoryapprovalmilestonespayable": 190000000,
    "commercialmilestonepaymentsperproduct": 170000000,
    "aggregateamountofcommercialmilestonespayable": 1400000000,
    "proceedsfromcontributedcapital": 115000000,
    "cash": 10000000,
    "sharesissuedpricepershare": 10,
    "contractualobligationdescriptionrepaymenttiming": "earlier of FDA approval or May 1, 2025",
    "fairvalueoptionchangesinfairvaluegainloss1": -9173000,
    "debtinstrumentfaceamount": 345000000,
    "debtinstrumentfrequencyofperiodicpayment": "semi-annually",
    "debtinstrumentpaymentterms": "The 2027 Notes accrue interest at a rate of 2.50% per annum, payable semi-annually in arrears on February 15 and August 15 of each year, beginning on February 15, 2023.",
    "interestpayablecurrent": 3200000,
    "debtinstrumentunamortizeddiscountpremiumnet": 7576000,
    "debtinstrumentcarryingamount": 337424000,
    "interestexpensedebtexcludingamortization": 8625000,
    "interestexpensedebt": 10567000,
    "debtinstrumentinterestrateeffectivepercentage": 0.031,
    "longtermdebtmaturitiesrepaymentsofprincipalinnexttwelvemonths": 8625000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyeartwo": 8625000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearthree": 8625000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearfour": 353625000,
    "longtermdebt": 379500000,
    "debtinstrumentinterest": 34500000,
    "cashandcashequivalentsfairvaluedisclosure": 1960000,
    "assetsfairvaluedisclosure": 415681000,
    "liabilitiesfairvaluedisclosure": 56082000,
    "marketablesecuritiesweightedaveragematurityterm": "P8M",
    "availableforsalesecuritiesdebtsecurities": 43538000,
    "financingliabilityrelatedpartyandfinancingliabilitymeasurementinput": 0.09,
    "debtinstrumentfairvalue": 382000000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 43487000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 71000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 20000,
    "fairvaluemeasurementwithunobservableinputsreconciliationsrecurringbasisliabilityvalue": 112164000,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisfundingcommitmentreceived": 31250000,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilitygainlossincludedinearnings": 18346000,
    "fairvaluerecurringbasisunobservableinputreconciliationliabilitygainlossstatementofincomeextensiblelist": "http://fasb.org/us-gaap/2023#OtherNonoperatingIncomeExpense",
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilitygainlossincludedinothercomprehensiveincome": 5220000,
    "fairvaluerecurringbasisunobservableinputreconciliationliabilitygainlossstatementofothercomprehensiveincomeextensiblelist": "http://fasb.org/us-gaap/2023#OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax",
    "prepaidclinicaltrialservicescurrent": 1717000,
    "prepaidresearchanddevelopmentexpensescurrent": 1821000,
    "prepaidinsurance": 2608000,
    "otherprepaidexpensecurrent": 3973000,
    "interestreceivablecurrent": 5291000,
    "otherassetscurrent": 563000,
    "propertyplantandequipmentgross": 1045000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 12566000,
    "depreciation": 5300000,
    "prepaidexpenseothernoncurrent": 1886000,
    "deferredfinancecostsnoncurrentnet": 122000,
    "otherassetsmiscellaneousnoncurrent": 1421000,
    "accruedexternalresearchanddevelopmentservicescurrent": 51300000,
    "employeerelatedliabilitiescurrent": 19423000,
    "accruedprofessionalfeescurrent": 1786000,
    "otheraccruedliabilitiescurrent": 1169000,
    "gainlossonfairvalueremeasurementoffinancingliabilityrelatedparty": -9173000,
    "gainlossonfairvalueremeasurementoffinancingliability": -9173000,
    "othernonoperatingincomeexpenseother": -26000,
    "operatingleasecost": 4906000,
    "variableleasecost": 2357000,
    "leasecost": 7263000,
    "operatingleasepayments": 6095000,
    "operatingleaseweightedaverageremainingleaseterm1": "P6Y2M1D",
    "operatingleaseweightedaveragediscountratepercent": 0.099,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 6289000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 6457000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 6661000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 6861000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 7078000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 8484000,
    "lesseeoperatingleaseliabilitypaymentsdue": 41830000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 10640000,
    "operatingleaseliability": 31190000,
    "operatingleaseassets": 20125000,
    "commonstockvotingrights": "one vote",
    "classofwarrantorrighstdatefromwhichwarrantsorrightsexercisable": "2021-06-09",
    "allocatedsharebasedcompensationexpense": 27895000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 17151253,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 14334620,
    "stockoptionawardexercisepriceaspercentageoffairmarketvalue": 1,
    "stockoptionplanterm": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrights": "Stock options granted to employees under our plan generally vest, if at all, as follows: 25% will vest on the first anniversary of the vesting start date, with the remaining 75% to vest ratably in 36 equal monthly installments thereafter until the award fully vests upon the fourth anniversary of the vesting start date.",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightsremainingpercentage": 0.75,
    "shareoptionsgrantedinstallments": "36 equal monthly installments",
    "numberofinstallmentsofshareoptionsgranted": 36,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 39100000,
    "closingpriceofcommonstock": 42.4,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 25.11,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 105200000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 17500000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodtotalfairvalue": 12600000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 16559240,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 1065944,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 31.87,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0382,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y21D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.892,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiod": 2842487,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiod": 1081131,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 17151253,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 11341491,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 16.64,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 33.12,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 9.22,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 23.9,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 16.64,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 11.38,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P6Y11M1D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P6Y11M1D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P6Y2M8D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 441900,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 441900,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 351800,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 703142,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 305375,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 76359,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 31.13,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 32.61,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 34.41,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 17151253,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationtaxsettlementsstateandlocal": 0.071,
    "effectiveincometaxratereconciliationexecutivecompensation": 0.018,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedcompensationcost": 0.014,
    "effectiveincometaxratereconciliationtaxcredits": 0.028,
    "effectiveincometaxratereconciliationotheradjustments": -0.001,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.305,
    "effectiveincometaxratecontinuingoperations": -0.001,
    "deferredtaxassetsoperatinglosscarryforwards": 146495000,
    "deferredtaxassetsinprocessresearchanddevelopment": 136090000,
    "deferredtaxassetoperatingleaseliabilities": 8513000,
    "deferredtaxassetstaxcreditcarryforwards": 37165000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 22171000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 4592000,
    "deferredtaxassetamortization": 583000,
    "deferredtaxassetsfinancingliabilities": 30834000,
    "deferredtaxassetsother": 1976000,
    "deferredtaxassetsgross": 388419000,
    "deferredtaxassetsvaluationallowance": 376948000,
    "deferredtaxassetsnet": 11471000,
    "deferredtaxliabilitiesdepreciation": 2725000,
    "deferredtaxliabilitiesleasingarrangements": 5493000,
    "deferredtaxliabilitiesprepaidexpenses": 2761000,
    "deferredtaxliabilitiesother": 492000,
    "deferredincometaxliabilities": 11471000,
    "valuationallowancedeferredtaxassetchangeinamount": 131600000,
    "researchanddevelopmentexpenditurecapitalizationandamortizationperiod": "P5Y",
    "deferredtaxassetsoperatinglosscarryforwardsnotsubjecttoexpiration": 533200000,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 549000000,
    "operatinglosscarryforwardsexpirationyear": 2031,
    "taxcreditcarryforwardamount": 33300000,
    "taxcreditcarryforwardexpirationyear": 2039,
    "deferredtaxassetsoperatinglosscarryforwardssubjecttoexpiration": 542200000,
    "currentstateandlocaltaxexpensebenefit": 503000,
    "definedcontributionplancostrecognized": 4000000,
    "numberofmembersnominatedtoboardofdirectors": 2
  },
  {
    "date": "2022-12-30",
    "symbol": "CERE",
    "period": "FY",
    "entityregistrantname": "CEREVEL THERAPEUTICS HOLDINGS, INC.",
    "entitycentralindexkey": 1805387,
    "amendmentflag": "false",
    "currentfiscalyearenddate": "--12-31",
    "documenttype": "10-K",
    "documentperiodenddate": "2022-12-31",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityfilercategory": "Large Accelerated Filer",
    "entityshellcompany": "false",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "false",
    "icfrauditorattestationflag": "true",
    "entityfilenumber": "001-39311",
    "entitytaxidentificationnumber": "85-3911080",
    "entityaddressaddressline1": "222 Jacobs Street",
    "entityaddressaddressline2": "Suite 200",
    "entityaddresscityortown": "Cambridge",
    "entityaddressstateorprovince": "MA",
    "entityaddresspostalzipcode": 2141,
    "cityareacode": 844,
    "localphonenumber": "304-2048",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "Common stock, par value $0.0001 per share",
    "tradingsymbol": "CERE",
    "securityexchangename": "NASDAQ",
    "entityincorporationstatecountrycode": "DE",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "auditorname": "Ernst & Young LLP",
    "auditorlocation": "Boston, Massachusetts",
    "auditorfirmid": 42,
    "cashandcashequivalentsatcarryingvalue": 136521000,
    "availableforsalesecuritiesdebtsecuritiescurrent": 755509000,
    "prepaidexpenseandotherassetscurrent": 13621000,
    "assetscurrent": 905651000,
    "availableforsalesecuritiesdebtsecuritiesnoncurrent": 58126000,
    "propertyplantandequipmentnet": 27467000,
    "operatingleaserightofuseasset": 21820000,
    "restrictedcashandcashequivalentsnoncurrent": 1867000,
    "otherassetsnoncurrent": 2891000,
    "assets": 1017822000,
    "accountspayablecurrent": 10061000,
    "accruedliabilitiesandotherliabilities": 59604000,
    "operatingleaseliabilitycurrent": 2899000,
    "liabilitiescurrent": 72564000,
    "operatingleaseliabilitynoncurrent": 31190000,
    "noncurrentfinancingliabilityrelatedparty": 28674000,
    "noncurrentfinancingliability": 28674000,
    "convertibledebtnoncurrent": 335482000,
    "liabilities": 496584000,
    "commonstockvalue": 16000,
    "additionalpaidincapital": 1485880000,
    "accumulatedothercomprehensiveincomelossnetoftax": 3097000,
    "retainedearningsaccumulateddeficit": -967755000,
    "stockholdersequity": 521238000,
    "liabilitiesandstockholdersequity": 1017822000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 500000000,
    "commonstocksharesissued": 156502285,
    "commonstocksharesoutstanding": 156502285,
    "researchanddevelopmentexpense": 280259000,
    "generalandadministrativeexpense": 87589000,
    "operatingexpenses": 367848000,
    "operatingincomeloss": -367848000,
    "interestincomeexpensenonoperatingnet": 9619000,
    "othernonoperatingincomeexpense": 6878000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -351351000,
    "incometaxexpensebenefit": 160000,
    "netincomeloss": -351511000,
    "netincomelossavailabletocommonstockholdersbasic": -351511000,
    "earningspersharebasic": -2.32,
    "earningspersharediluted": -2.32,
    "weightedaveragenumberofsharesoutstandingbasic": 151265635,
    "weightedaveragenumberofdilutedsharesoutstanding": 151265635,
    "othercomprehensiveincomelossfinancialliabilityfairvalueoptionunrealizedgainlossarisingduringperiodaftertax": 6816000,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": -2733000,
    "othercomprehensiveincomelossnetoftax": 4083000,
    "comprehensiveincomenetoftax": -347428000,
    "sharesoutstanding": 156502285,
    "stockissuedduringperiodvaluenewissues": 1000,
    "stockissuedduringperiodsharesnewissues": 7250000,
    "stockissuedduringperiodsharessharebasedcompensation": 28540,
    "stockissuedduringperiodvaluestockoptionsexercised": 11697000,
    "stockissuedduringperiodsharesstockoptionsexercised": 1443897,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 1355000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 60325,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 38780000,
    "profitloss": -351511000,
    "depreciationdepletionandamortization": 4903000,
    "adjustmentstooperatingleaseexpense": 1012000,
    "sharebasedcompensation": 38780000,
    "changeinfairvalueoffinancingliability": -6876000,
    "amortizationoffinancingcosts": 708000,
    "accretionamortizationofdiscountsandpremiumsinvestments": 6549000,
    "othernoncashincomeexpense": -306000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 1139000,
    "increasedecreaseinotheroperatingassets": 841000,
    "increasedecreaseinaccountspayable": -763000,
    "increasedecreaseinaccruedliabilities": 30807000,
    "netcashprovidedbyusedinoperatingactivities": -293187000,
    "paymentstoacquiremarketablesecurities": 887737000,
    "proceedsfromsaleandmaturityofmarketablesecurities": 502857000,
    "paymentstoacquirepropertyplantandequipment": 3954000,
    "netcashprovidedbyusedininvestingactivities": -388834000,
    "proceedsfromissuanceofcommonstock": 238263000,
    "proceedsfromissuanceofsharesunderincentiveandsharebasedcompensationplansincludingstockoptions": 13052000,
    "proceedsfromrelatedpartydebt": 18750000,
    "proceedsfromissuanceoflongtermdebtexcludingrelatedpartydebt": 18750000,
    "proceedsfromconvertibledebt": 334774000,
    "paymentsoffinancingcosts": 398000,
    "netcashprovidedbyusedinfinancingactivities": 623191000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": -58830000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 138388000,
    "capitalexpendituresincurredbutnotyetpaid": 329000,
    "offeringcostsincludedinaccountspayableandothercurrentliabilities": 139000,
    "reclassificationofdeferredfinancingcoststoadditionalpaidincapital": 158000,
    "businesscombinationexchangeratiodescription": "The shares and corresponding capital amounts and loss per share related to Old Cerevelâ€™s outstanding redeemable convertible preferred stock, redeemable convertible common stock and common stock prior to the Business Combination Transaction have been retroactively restated to give effect to the exchange ratio established in the Business Combination Agreement (1.00 Old Cerevel share for 2.854 shares of New Cerevel), or the Exchange Ratio.",
    "stockexchangeratio": 2.854,
    "managementfeepayable": 3000000,
    "proceedsfromissuanceorsaleofequity": 350000000,
    "decreaseinaccumulateddeficit": 3900000,
    "numberofoperatingsegments": 1,
    "numberofreportablesegments": 1,
    "revenuefromcontractwithcustomerexcludingassessedtax": 500000000,
    "increasedecreaseinresearchanddevelopmentexpense": -4400000,
    "researchanddevelopmentqualifyingcostsreimbursementreceivable": 1400000,
    "restrictedcash": 1867000,
    "propertyplantandequipmentusefullife": "P3Y",
    "propertyplantandequipmentestimatedusefullives": "Shorter of useful life or remaining lease term",
    "changeinaccountingprincipleaccountingstandardsupdateadopted": "true",
    "changeinaccountingprincipleaccountingstandardsupdateadoptiondate": "2022-01-01",
    "changeinaccountingprincipleaccountingstandardsupdateimmaterialeffect": "true",
    "regulatoryapprovalmilestonepayments": 7500000,
    "aggregateamountofregulatoryapprovalmilestonespayable": 190000000,
    "commercialmilestonepaymentsperproduct": 170000000,
    "aggregateamountofcommercialmilestonespayable": 1400000000,
    "proceedsfromcontributedcapital": 115000000,
    "cash": 10000000,
    "sharesissuedpricepershare": 10,
    "contractualobligationdescriptionrepaymenttiming": "earlier of FDA approval or May 1, 2025",
    "fairvalueoptionchangesinfairvaluegainloss1": -3438000,
    "debtinstrumentfaceamount": 345000000,
    "debtinstrumentfrequencyofperiodicpayment": "semi-annually",
    "debtinstrumentpaymentterms": "The 2027 Notes accrue interest at a rate of 2.50% per annum, payable semi-annually in arrears on February 15 and August 15 of each year, beginning on February 15, 2023.",
    "interestpayablecurrent": 3200000,
    "debtinstrumentunamortizeddiscountpremiumnet": 9518000,
    "debtinstrumentcarryingamount": 335482000,
    "interestexpensedebtexcludingamortization": 3210000,
    "interestexpensedebt": 3918000,
    "debtinstrumentinterestrateeffectivepercentage": 0.031,
    "longtermdebtmaturitiesrepaymentsofprincipalinnexttwelvemonths": 8601000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyeartwo": 8625000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearthree": 8625000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearfour": 8625000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearfive": 353625000,
    "longtermdebt": 388101000,
    "debtinstrumentinterest": 43101000,
    "cashandcashequivalentsfairvaluedisclosure": 136521000,
    "assetsfairvaluedisclosure": 1867000,
    "liabilitiesfairvaluedisclosure": 28674000,
    "marketablesecuritiesweightedaveragematurityterm": "P5M",
    "availableforsalesecuritiesdebtsecurities": 103238000,
    "financingliabilityrelatedpartyandfinancingliabilitymeasurementinput": 0.1,
    "debtinstrumentfairvalue": 341700000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 103800000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 15000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 562000,
    "fairvaluemeasurementwithunobservableinputsreconciliationsrecurringbasisliabilityvalue": 57348000,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisfundingcommitmentreceived": 37500000,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilitygainlossincludedinearnings": -6876000,
    "fairvaluerecurringbasisunobservableinputreconciliationliabilitygainlossstatementofincomeextensiblelist": "http://fasb.org/us-gaap/2022#OtherNonoperatingIncomeExpense",
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilitygainlossincludedinothercomprehensiveincome": -6816000,
    "fairvaluerecurringbasisunobservableinputreconciliationliabilitygainlossstatementofothercomprehensiveincomeextensiblelist": "http://fasb.org/us-gaap/2022#OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionUnrealizedGainLossArisingDuringPeriodAfterTax",
    "prepaidclinicaltrialservicescurrent": 2872000,
    "prepaidresearchanddevelopmentexpensescurrent": 1228000,
    "prepaidinsurance": 2460000,
    "otherprepaidexpensecurrent": 3556000,
    "interestreceivablecurrent": 2046000,
    "otherassetscurrent": 1459000,
    "propertyplantandequipmentgross": 996000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 7259000,
    "depreciation": 4700000,
    "prepaidexpenseothernoncurrent": 1792000,
    "deferredfinancecostsnoncurrentnet": 286000,
    "otherassetsmiscellaneousnoncurrent": 813000,
    "accruedexternalresearchanddevelopmentservicescurrent": 33967000,
    "employeerelatedliabilitiescurrent": 19057000,
    "accruedpropertyandequipmentcurrent": 40000,
    "accruedprofessionalfeescurrent": 2187000,
    "otheraccruedliabilitiescurrent": 1143000,
    "interestincomenonoperatingnet": 13537000,
    "interestexpense": 3918000,
    "gainlossonfairvalueremeasurementoffinancingliabilityrelatedparty": 3438000,
    "gainlossonfairvalueremeasurementoffinancingliability": 3438000,
    "othernonoperatingincomeexpenseother": 2000,
    "leasecommencementdate": "2019-04-30",
    "leasedateoftermination": "2020-11-30",
    "operatingleaseofficelocation": "131 Dartmouth Street, Boston, Massachusetts",
    "operatingleasecost": 4906000,
    "variableleasecost": 1994000,
    "leasecost": 6900000,
    "operatingleasepayments": 5918000,
    "operatingleaseweightedaverageremainingleaseterm1": "P7Y2M1D",
    "operatingleaseweightedaveragediscountratepercent": 0.099,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 6096000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 6289000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 6457000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 6661000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 6861000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 15562000,
    "lesseeoperatingleaseliabilitypaymentsdue": 47926000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 13837000,
    "operatingleaseliability": 34089000,
    "operatingleaseassets": 21820000,
    "commonstockvotingrights": "one vote",
    "classofwarrantorrighstdatefromwhichwarrantsorrightsexercisable": "2021-06-09",
    "allocatedsharebasedcompensationexpense": 18206000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 17178861,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 14797463,
    "stockoptionawardexercisepriceaspercentageoffairmarketvalue": 1,
    "stockoptionplanterm": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrights": "Stock options granted to employees under our plans generally vest, if at all, as follows: 25% will vest on the first anniversary of the vesting start date, with the remaining 75% to vest ratably in 36 equal monthly installments thereafter until the award fully vests upon the fourth anniversary of the vesting start date.",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightsremainingpercentage": 0.75,
    "shareoptionsgrantedinstallments": "36 equal monthly installments",
    "numberofinstallmentsofshareoptionsgranted": 36,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 33500000,
    "closingpriceofcommonstock": 31.54,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 23.22,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 99400000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 400000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodtotalfairvalue": 900000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y9M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 16559240,
    "sharebasedcompensationarrangementbysharebasedpaymentawardmaximumavailablevestingamountdescription": "The Available Vesting Amount was equal to the number of shares subject to the stock option multiplied by an equity ratio of total capital received from investors (up to a maximum of $350.0 million) divided by $350.0 million.",
    "percentageoffullydilutedshares": 0.1,
    "capitalunitsnetamount": 350000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0223,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.962,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiod": 3245369,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiod": 688675,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 17178861,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 9678243,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 13.59,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 29.82,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 8.1,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 15.93,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 13.59,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 8.19,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y6M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P7Y6M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P6Y9M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 309900000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 309900000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 226200000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 18932,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 18932,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 28540,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 26.41,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 26.41,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 2.1,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 17178861,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationtaxsettlementsstateandlocal": 0.064,
    "effectiveincometaxratereconciliationexecutivecompensation": 0.012,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedcompensationcost": 0.015,
    "effectiveincometaxratereconciliationtaxcredits": 0.03,
    "effectiveincometaxratereconciliationotheradjustments": -0.001,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.306,
    "deferredtaxassetsoperatinglosscarryforwards": 121799000,
    "deferredtaxassetsinprocessresearchanddevelopment": 67283000,
    "deferredtaxassetoperatingleaseliabilities": 9145000,
    "deferredtaxassetstaxcreditcarryforwards": 23864000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 12923000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 4253000,
    "deferredtaxassetamortization": 632000,
    "deferredtaxassetsfinancingliabilities": 17001000,
    "deferredtaxassetsgross": 256900000,
    "deferredtaxassetsvaluationallowance": 245392000,
    "deferredtaxassetsnet": 11508000,
    "deferredtaxliabilitiesdepreciation": 2940000,
    "deferredtaxliabilitiesleasingarrangements": 5854000,
    "deferredtaxliabilitiesprepaidexpenses": 2714000,
    "deferredincometaxliabilities": 11508000,
    "valuationallowancedeferredtaxassetchangeinamount": 107500000,
    "researchanddevelopmentexpenditurecapitalizationandamortizationperiod": "P5Y",
    "deferredtaxassetsoperatinglosscarryforwardsnotsubjecttoexpiration": 448700000,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 438300000,
    "operatinglosscarryforwardsexpirationyear": 2031,
    "taxcreditcarryforwardamount": 21300000,
    "taxcreditcarryforwardexpirationyear": 2039,
    "deferredtaxassetsoperatinglosscarryforwardssubjecttoexpiration": 433400000,
    "currentstateandlocaltaxexpensebenefit": 160000,
    "definedcontributionplancostrecognized": 3100000,
    "numberofmembersnominatedtoboardofdirectors": 2
  },
  {
    "date": "2021-12-30",
    "symbol": "CERE",
    "period": "FY",
    "entityregistrantname": "CEREVEL THERAPEUTICS HOLDINGS, INC.",
    "entitycentralindexkey": 1805387,
    "amendmentflag": "false",
    "currentfiscalyearenddate": "--12-31",
    "documenttype": "10-K",
    "documentperiodenddate": "2021-12-31",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityfilercategory": "Large Accelerated Filer",
    "entityshellcompany": "false",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "false",
    "icfrauditorattestationflag": "true",
    "entityfilenumber": "001-39311",
    "entitytaxidentificationnumber": "85-3911080",
    "entityaddressaddressline1": "222 Jacobs Street",
    "entityaddressaddressline2": "Suite 200",
    "entityaddresscityortown": "Cambridge",
    "entityaddressstateorprovince": "MA",
    "entityaddresspostalzipcode": 2141,
    "cityareacode": 844,
    "localphonenumber": "304-2048",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "Common stock, par value $0.0001 per share",
    "tradingsymbol": "CERE",
    "securityexchangename": "NASDAQ",
    "entityincorporationstatecountrycode": "DE",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "auditorname": "Ernst & Young LLP",
    "auditorlocation": "Boston, Massachusetts",
    "auditorfirmid": 42,
    "cashandcashequivalentsatcarryingvalue": 193018000,
    "availableforsalesecuritiesdebtsecuritiescurrent": 372670000,
    "prepaidexpenseandotherassetscurrent": 12329000,
    "assetscurrent": 578017000,
    "availableforsalesecuritiesdebtsecuritiesnoncurrent": 52269000,
    "propertyplantandequipmentnet": 28449000,
    "operatingleaserightofuseasset": 23251000,
    "restrictedcashandcashequivalentsnoncurrent": 4200000,
    "otherlongtermassets": 2733000,
    "assets": 688919000,
    "accountspayablecurrent": 11298000,
    "accruedliabilitiesandotherliabilities": 28803000,
    "operatingleaseliabilitycurrent": 2437000,
    "liabilitiescurrent": 42538000,
    "operatingleaseliabilitynoncurrent": 34110000,
    "noncurrentfinancingliabilityrelatedparty": 16770000,
    "noncurrentfinancingliability": 16770000,
    "otherliabilitiesnoncurrent": 2000,
    "liabilities": 110190000,
    "commonstockvalue": 15000,
    "additionalpaidincapital": 1195944000,
    "accumulatedothercomprehensiveincomelossnetoftax": -986000,
    "retainedearningsaccumulateddeficit": -616244000,
    "stockholdersequity": 578729000,
    "liabilitiesandstockholdersequity": 688919000,
    "preferredstockparorstatedvaluepershare": 0.0001,
    "preferredstocksharesauthorized": 10000000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 500000000,
    "commonstocksharesissued": 147719523,
    "commonstocksharesoutstanding": 147719523,
    "researchanddevelopmentexpense": 161855000,
    "generalandadministrativeexpense": 58243000,
    "operatingexpenses": 220098000,
    "operatingincomeloss": -220098000,
    "interestincomeexpensenonoperatingnet": 157000,
    "othernonoperatingincomeexpense": -5393000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -225334000,
    "netincomeloss": -225334000,
    "netincomelossavailabletocommonstockholdersbasic": -225334000,
    "earningspersharebasicanddiluted": -1.65,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 136576536,
    "othercomprehensiveincomelossfinancialliabilityfairvalueoptionunrealizedgainlossarisingduringperiodaftertax": -788000,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": -198000,
    "othercomprehensiveincomelossnetoftax": -986000,
    "comprehensiveincomenetoftax": -226320000,
    "sharesoutstanding": 147719523,
    "issuanceofcommonstockrelatedtofollowonofferingnetofofferingcosts": 1000,
    "issuanceofcommonstockrelatedtofollowonofferingshares": 14000000,
    "issuanceofcommonstockvaluerelatedtoexerciseofpublicwarrants": 1000,
    "issuanceofcommonstocksharesrelatedtoexerciseofpublicwarrants": 4822947,
    "stockissuedduringperiodvalueexerciseofprivateplacementwarrants": 4186000,
    "stockissuedduringperiodsharesexerciseofprivateplacementwarrants": 111426,
    "stockissuedduringperiodsharessharebasedcompensation": 42810,
    "stockissuedduringperiodvaluestockoptionsexercised": 8067000,
    "stockissuedduringperiodsharesstockoptionsexercised": 1533914,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 926000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 84472,
    "adjustmentstoadditionalpaidincapitalreclassificationofwarrants": 305000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 23941000,
    "profitloss": -225334000,
    "depreciationdepletionandamortization": 2731000,
    "adjustmentstooperatingleaseexpense": 830000,
    "sharebasedcompensation": 23941000,
    "changeinfairvalueoffinancingliability": 1502000,
    "fairvalueadjustmentofwarrants": 3881000,
    "othernoncashincomeexpense": -22000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 5271000,
    "increasedecreaseinotheroperatingassets": 733000,
    "increasedecreaseinaccountspayable": 7278000,
    "increasedecreaseinaccountspayableandotheroperatingliabilities": 8672000,
    "increasedecreaseinoperatingleaseliabilities": 5595000,
    "netcashprovidedbyusedinoperatingactivities": -178546000,
    "paymentstoacquiremarketablesecurities": 425158000,
    "paymentstoacquirepropertyplantandequipment": 10503000,
    "netcashprovidedbyusedininvestingactivities": -435661000,
    "proceedsfromissuanceofcommonstock": 328251000,
    "proceedsfrombusinesscombinationtransactionnetofofferingcosts": -140000,
    "proceedsfromwarrantexercises": 55463000,
    "proceedsfromexerciseofstockoptionsandespppurchases": 8993000,
    "proceedsfromrelatedpartydebt": 15625000,
    "proceedsfromissuanceoflongtermdebtexcludingrelatedpartydebt": 15625000,
    "paymentsoffinancingcosts": 215000,
    "netcashprovidedbyusedinfinancingactivities": 423602000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": -190605000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 197218000,
    "fixedassetadditionsincludedinaccountspayableandothercurrentliabilities": 747000,
    "unpaidofferingcostsincludedinaccountspayableandothercurrentliabilities": 270000,
    "cashlessexerciseofprivateplacementwarrants": 4186000,
    "businesscombinationexchangeratiodescription": "The shares and corresponding capital amounts and loss per share related to Old Cerevelâ€™s outstanding redeemable convertible preferred stock, redeemable convertible common stock and common stock prior to the Business Combination Transaction have been retroactively restated to give effect to the exchange ratio established in the Business Combination Agreement (1.00 Old Cerevel share for 2.854 shares of New Cerevel), or the Exchange Ratio.",
    "stockexchangeratio": 2.854,
    "managementfeepayable": 3000000,
    "proceedsfromissuanceorsaleofequity": 350000000,
    "decreaseinaccumulateddeficit": 3900000,
    "numberofoperatingsegments": 1,
    "numberofreportablesegments": 1,
    "revenuefromcontractwithcustomerexcludingassessedtax": 500000000,
    "increasedecreaseinresearchanddevelopmentexpense": -900000,
    "researchanddevelopmentqualifyingcostsreimbursementreceivable": 200000,
    "changeinaccountingprincipleaccountingstandardsupdateadopted": "true",
    "changeinaccountingprincipleaccountingstandardsupdateadoptiondate": "2019-01-01",
    "restrictedcash": 4200000,
    "propertyplantandequipmentusefullife": "P3Y",
    "propertyplantandequipmentestimatedusefullives": "Shorter of useful life or remaining lease term",
    "changeinaccountingprincipleaccountingstandardsupdateimmaterialeffect": "true",
    "regulatoryapprovalmilestonepayments": 7500000,
    "aggregateamountofregulatoryapprovalmilestonespayable": 220000000,
    "commercialmilestonepaymentsperproduct": 170000000,
    "aggregateamountofcommercialmilestonespayable": 1700000000,
    "proceedsfromcontributedcapital": 115000000,
    "cash": 10000000,
    "sharesissuedpricepershare": 10,
    "receivedfunding": 15500000,
    "fundingcommitmentfeesincurred": 100000,
    "contractualobligationdescriptionrepaymenttiming": "earlier of FDA approval or May 1, 2025",
    "changeinfairvalueoffinancingliabilityrelatedparty": -800000,
    "cashandcashequivalentsfairvaluedisclosure": 153589000,
    "assetsfairvaluedisclosure": 4200000,
    "liabilitiesfairvaluedisclosure": 16770000,
    "changeinfairvalueofprivateplacementwarrants": 3900000,
    "marketablesecuritiesweightedaveragematurityterm": "P8M18D",
    "availableforsalesecuritiesdebtsecurities": 424939000,
    "financingliabilityrelatedpartyandfinancingliabilitymeasurementinput": 0.09,
    "availableforsalesecuritiesdebtmaturitieswithinoneyearamortizedcost": 171111000,
    "availableforsalesecuritiesdebtmaturitieswithinoneyearaccumulatedgrossunrealizedgainbeforetax": 11000,
    "availableforsalesecuritiesdebtmaturitieswithinoneyearaccumulatedgrossunrealizedlossbeforetax": 48000,
    "availableforsalesecuritiesdebtmaturitieswithinoneyearfairvalue": 171063000,
    "availableforsalesecuritiesdebtmaturitiesafteronethroughtwoyearsamortizedcost": 52387000,
    "availableforsalesecuritiesdebtmaturitiesafteronethroughtwoyearsaccumulatedgrossunrealizedlossbeforetax": 118000,
    "availableforsalesecuritiesdebtmaturitiesafteronethroughtwoyearsfairvalue": 52269000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 425138000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 11000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedlossbeforetax": 210000,
    "fairvaluemeasurementwithunobservableinputsreconciliationsrecurringbasisliabilityvalue": -33540000,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilityissues": 31250000,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilitygainlossincludedinearnings": -1502000,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilitygainlossincludedinothercomprehensiveincome": -788000,
    "prepaidclinicaltrialservicescurrent": 2038000,
    "prepaidresearchanddevelopmentexpensescurrent": 2074000,
    "prepaidinsurance": 4701000,
    "otherprepaidexpensecurrent": 2225000,
    "interestreceivablecurrent": 729000,
    "otherassetscurrent": 562000,
    "propertyplantandequipmentgross": 946000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 2566000,
    "depreciation": 2500000,
    "prepaidexpenseothernoncurrent": 1806000,
    "deferredfinancecostsnoncurrentnet": 485000,
    "otherassetsmiscellaneousnoncurrent": 442000,
    "accruedexternalresearchanddevelopmentservicescurrent": 16097000,
    "accruedsalariescurrentandnoncurrent": 10827000,
    "accruedpropertyandequipmentcurrent": 109000,
    "accrueddeferredexpensesassociatedwithfinancingactivitiescurrent": 125000,
    "accruedprofessionalfeescurrent": 1270000,
    "otheraccrualsandothercurrentliabilities": 375000,
    "gainlossonfairvalueremeasurementoffinancingliabilityrelatedparty": -751000,
    "gainlossonfairvalueremeasurementoffinancingliability": -751000,
    "gainlossonfairvalueremeasurementofprivateplacementwarrants": -3881000,
    "othernonoperatingincomeexpenseother": -10000,
    "leasecommencementdate": "2019-04-30",
    "leasedateoftermination": "2020-11-30",
    "operatingleaseofficelocation": "131 Dartmouth Street, Boston, Massachusetts",
    "reimbursementoftenantimprovementallowancefromlandlord": 12200000,
    "operatingleasecost": 4906000,
    "variableleasecost": 1512000,
    "leasecost": 6418000,
    "operatingleasepayments": 5736000,
    "operatingleaseweightedaverageremainingleaseterm1": "P8Y2M1D",
    "operatingleaseweightedaveragediscountratepercent": 0.099,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 5918000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 6096000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 6289000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 6457000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 6661000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 22423000,
    "lesseeoperatingleaseliabilitypaymentsdue": 53844000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 17297000,
    "operatingleaseliability": 36547000,
    "operatingleaseassets": 23251000,
    "commonstockvotingrights": "one vote",
    "classofwarrantorrighstdatefromwhichwarrantsorrightsexercisable": "2021-06-09",
    "allocatedsharebasedcompensationexpense": 9220000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 16066064,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 11464309,
    "stockoptionawardexercisepriceaspercentageoffairmarketvalue": 1,
    "stockoptionplanterm": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrights": "Stock options granted to employees under our plans generally vest, if at all, as follows: 25% will vest on the first anniversary of the vesting start date, with the remaining 75% to vest ratably in 36 equal monthly installments thereafter until the award fully vests upon the fourth anniversary of the vesting start date.",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightsremainingpercentage": 0.75,
    "shareoptionsgrantedinstallments": "36 equal monthly installments",
    "numberofinstallmentsofshareoptionsgranted": 36,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 33400000,
    "closingpriceofcommonstock": 32.42,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 11.36,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 70100000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 100000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P3Y1M6D",
    "proceedsfromissuanceofsharesunderincentiveandsharebasedcompensationplansincludingstockoptions": 900000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 16559240,
    "sharebasedcompensationarrangementbysharebasedpaymentawardmaximumavailablevestingamountdescription": "The Available Vesting Amount was equal to the number of shares subject to the stock option multiplied by an equity ratio of total capital received from investors (up to a maximum of $350.0 million) divided by $350.0 million.",
    "percentageoffullydilutedshares": 0.1,
    "capitalunitsnetamount": 350000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.008,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.935,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiod": 6912651,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 1777341,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 16066064,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 5774797,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 9.92,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 15.07,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 5.26,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 9.06,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 9.92,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 5.82,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P8Y1M2D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P8Y1M2D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P6Y11M19D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 362250000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 362250000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 153636000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 28540,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 42810,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 2.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 1.97,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 16066064,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationtaxsettlementsstateandlocal": 0.064,
    "effectiveincometaxratereconciliationexecutivecompensation": 0.023,
    "effectiveincometaxratereconciliationnondeductibleexpensefairvalueadjustment": 0.004,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedcompensationcost": 0.027,
    "effectiveincometaxratereconciliationtaxcredits": 0.023,
    "effectiveincometaxratereconciliationotheradjustments": 0.009,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.306,
    "deferredtaxassetsoperatinglosscarryforwards": 109837000,
    "deferredtaxassetoperatingleaseliabilities": 9877000,
    "deferredtaxassetstaxcreditcarryforwards": 12144000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 6436000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 2358000,
    "deferredtaxassetamortization": 745000,
    "deferredtaxassetsfinancingliabilities": 8852000,
    "deferredtaxassetsgross": 150249000,
    "deferredtaxassetsvaluationallowance": 137865000,
    "deferredtaxassetsnet": 12384000,
    "deferredtaxliabilitiesdepreciation": 3138000,
    "deferredtaxliabilitiesleasingarrangements": 6283000,
    "deferredtaxliabilitiesprepaidexpenses": 2963000,
    "deferredincometaxliabilities": 12384000,
    "valuationallowancedeferredtaxassetchangeinamount": 68900000,
    "deferredtaxassetsoperatinglosscarryforwardsnotsubjecttoexpiration": 406200000,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 390900000,
    "operatinglosscarryforwardsexpirationyear": 2031,
    "taxcreditcarryforwardamount": 10800000,
    "taxcreditcarryforwardexpirationyear": 2041,
    "currentstateandlocaltaxexpensebenefit": 2000,
    "deferredfederalincometaxexpensebenefit": -2000,
    "definedcontributionplanadministrativeexpenses": 1700000,
    "numberofmembersappointedtoboardofdirectors": 2,
    "periodoverwhichfundingsupportreceived": "P4Y"
  },
  {
    "date": "2020-12-30",
    "symbol": "CERE",
    "period": "FY",
    "entityregistrantname": "Cerevel Therapeutics Holdings, Inc.",
    "entitycentralindexkey": 1805387,
    "amendmentflag": "false",
    "currentfiscalyearenddate": "--12-31",
    "documenttype": "10-K",
    "documentperiodenddate": "2020-12-31",
    "documentfiscalyearfocus": 2020,
    "documentfiscalperiodfocus": "FY",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entityshellcompany": "false",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "entityfilenumber": "001-39311",
    "entitytaxidentificationnumber": "85-3911080",
    "entityaddressaddressline1": "222 Jacobs Street",
    "entityaddressaddressline2": "Suite 200",
    "entityaddresscityortown": "Cambridge",
    "entityaddressstateorprovince": "MA",
    "entityaddresspostalzipcode": 2141,
    "cityareacode": 844,
    "localphonenumber": "304-2048",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "Warrants to purchase one share of common at an exercise price of $11.50",
    "tradingsymbol": "CEREW",
    "securityexchangename": "NASDAQ",
    "entityincorporationstatecountrycode": "DE",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "cashandcashequivalentsatcarryingvalue": 383623000,
    "prepaidexpenseandotherassetscurrent": 6937000,
    "assetscurrent": 390560000,
    "propertyplantandequipmentnet": 24165000,
    "operatingleaserightofuseasset": 24459000,
    "restrictedcashandcashequivalentsnoncurrent": 4200000,
    "otherlongtermassets": 1889000,
    "assets": 445273000,
    "accountspayablecurrent": 4993000,
    "accruedliabilitiesandotherliabilities": 22519000,
    "operatingleaseliabilitycurrent": 2036000,
    "liabilitiescurrent": 29548000,
    "operatingleaseliabilitynoncurrent": 30969000,
    "otherliabilitiesnoncurrent": 236000,
    "liabilities": 60753000,
    "commonstockvalue": 13000,
    "additionalpaidincapital": 775417000,
    "retainedearningsaccumulateddeficit": -390910000,
    "stockholdersequity": 350000000,
    "liabilitiesandstockholdersequity": 445273000,
    "preferredstockparorstatedvaluepershare": 10,
    "preferredstocksharesauthorized": 6900000,
    "commonstockparorstatedvaluepershare": 10,
    "commonstocksharesauthorized": 4600000,
    "commonstocksharesissued": 2500000,
    "commonstocksharesoutstanding": 60632356,
    "researchanddevelopmentexpense": 103303000,
    "generalandadministrativeexpense": 5000000,
    "operatingexpenses": 149116000,
    "operatingincomeloss": -149116000,
    "interestincomeother": 224000,
    "othernonoperatingincomeexpense": -3274000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -152166000,
    "incometaxexpensebenefit": -24000,
    "comprehensiveincomenetoftax": -152142000,
    "netincomeloss": -152142000,
    "temporaryequityaccretiontoredemptionvalueadjustment": -3871000,
    "netincomelossavailabletocommonstockholdersbasic": -148271000,
    "earningspersharebasicanddiluted": -2.01,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 73643315,
    "sharesoutstanding": 127123954,
    "stockissuedduringperiodvaluenewissues": 25000000,
    "stockissuedduringperiodsharesnewissues": 750000,
    "adjustmentstoadditionalpaidincapitalincreaseincarryingamountofredeemablepreferredstock": -3871000,
    "adjustmentstoadditionalpaidincapitalredemptionofcommonstockwithexchange": -1659000,
    "additionalstockissuedduringperiodvaluerelatedtoantidilutionprovisionsofpreferredstock": -2000,
    "additionalstockissuedduringperiodsharesrelatedtoantidilutionprovisionsofpreferredstock": 15208762,
    "stockissuedduringperiodvalueacquisitions": 417788000,
    "stockissuedduringperiodsharesacquisitions": 48441450,
    "stockissuedduringperiodsharesemployeebenefitplan": 42810,
    "adjustmentstoadditionalpaidincapitalpartialsettlementofequitycommitmentliabilityuponissuance": 5530000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 10521000,
    "profitloss": -152142000,
    "depreciationdepletionandamortization": 397000,
    "noncashrentexpenseunderoperatingleases": -88000,
    "sharebasedcompensation": 10521000,
    "changeinfairvalueofequitycommitment": 3530000,
    "changeinfairvalueofsharepurchaseoption": 260000,
    "writeoffofdeferredofferingcost": 2533000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -78000,
    "increasedecreaseinoperatingleaseassets": 342000,
    "increasedecreaseinotheroperatingassets": 715000,
    "increasedecreaseinaccountspayable": 1417000,
    "increasedecreaseinaccountspayableandotheroperatingliabilities": 10690000,
    "increasedecreaseinoperatingleaseliabilities": 6579000,
    "netcashprovidedbyusedinoperatingactivities": -117802000,
    "paymentstoacquirepropertyplantandequipment": 18892000,
    "netcashprovidedbyusedininvestingactivities": -18892000,
    "proceedsfromissuanceorsaleofequity": 450000000,
    "proceedsfrombusinesscombinationtransactionnetofofferingcostspaid": 442617000,
    "paymentoffinancingandstockissuancecosts": 1782000,
    "netcashprovidedbyusedinfinancingactivities": 440835000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": 304141000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 387823000,
    "fixedassetadditionsincludedinaccountspayableandothercurrentliabilities": 4488000,
    "unpaidofferingcostsincludedinaccountspayableandothercurrentliabilities": 140000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 445000,
    "settlementofequitycommitmentliabilityuponissuanceofseriesa1preferredstockandseriesacommonstock": 5530000,
    "shareprice": 11.5,
    "proceedsfrombusinessacquisition": 439493000,
    "classofwarrantorrightoutstanding": 166333,
    "businesscombinationexchangeratiodescription": "The shares and corresponding capital amounts and loss per share related to Old Cerevelâ€™s outstanding redeemable convertible preferred stock, redeemable convertible common stock and common stock prior to the Business Combination Transaction have been retroactively restated to reflect the exchange ratio established in the Business Combination Agreement (1.00 Old Cerevel share for 2.854 shares of New Cerevel), or the Exchange Ratio.",
    "stockexchangeratio": 2.854,
    "businesscombinationacquisitionrelatedcosts": 24600000,
    "managementfeepayable": 3000000,
    "subscriptionadvanceproceeds": 25000000,
    "subscriptionreceivablemaximum": 100000000,
    "aggregatestockredemptionamount": 25000000,
    "decreaseinaccumulateddeficit": 1700000,
    "prepaidexpensecurrentandnoncurrent": 300000,
    "cashacquiredfromacquisition": 320000000,
    "underwritingfeesandotherofferingcostspaidforbusinesscombination": 24505000,
    "proceedsfrombusinesscombinationtransactionnetofofferingcostspaidpercashflowsfromfinancingactivities": 442617000,
    "offeringcostsincludedinaccountspayableandothercurrentliabilities": 140000,
    "accelerationofmanagementfeespaidincludedingeneralandadministrativeexpense": 350000000,
    "commonstockoutstandingpriortobusinesscombinationtransaction": 19186500,
    "redemptionofsharespriortobusinesscombinationtransaction": 245050,
    "numberofsharesfrombusinesscombinationandprivateinvestmentinpublicequityfinancing": 50941450,
    "numberofsharesofcommonstockimmediatelyafterbusinesscombinationtransaction": 127123954,
    "numberofsharesofcommonstockoutstandingpriortobusinesscombinationconvertedbyexchangeratio": 71350,
    "restrictedcash": 4200000,
    "propertyplantandequipmentusefullife": "P5Y",
    "propertyplantandequipmentestimatedusefullives": "Shorter of useful life or remaining lease term",
    "revenuefromcontractwithcustomerexcludingassessedtax": 2000000000,
    "directtransactioncosts": 11000000,
    "businesscombinationconsiderationtransferred1": 111400000,
    "regulatoryapprovalmilestonepayments": 40000000,
    "aggregateamountofregulatoryapprovalmilestonespayable": 220000000,
    "commercialmilestonepaymentsperproduct": 170000000,
    "aggregateamountofcommercialmilestonespayable": 1700000000,
    "proceedsfromcontributedcapital": 100000000,
    "cash": 10000000,
    "sharesissuedpricepershare": 10,
    "equityfairvaluedisclosure": 149900,
    "assetsfairvaluedisclosure": 387823000,
    "fairvaluenetderivativeassetliabilitymeasuredonrecurringbasisunobservableinputsreconciliationgainlossincludedinearnings": -3530000,
    "fairvaluenetderivativeassetliabilitymeasuredonrecurringbasisunobservableinputsreconciliationsettlements": 5530000,
    "fairvaluemeasurementwithunobservableinputsreconciliationrecurringbasisliabilitygainlossincludedinearnings": 260000,
    "prepaidclinicaltrialservicescurrent": 172000,
    "prepaidresearchanddevelopmentexpensescurrent": 1650000,
    "prepaidinsurance": 3675000,
    "otherprepaidexpensecurrent": 1280000,
    "otherassetscurrent": 160000,
    "propertyplantandequipmentgross": 23728000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 82000,
    "depreciation": 200000,
    "prepaidexpenseothernoncurrent": 1389000,
    "otherassetsmiscellaneousnoncurrent": 500000,
    "accruedexternalresearchanddevelopmentservicescurrent": 8893000,
    "accruedsalariescurrentandnoncurrent": 9489000,
    "accruedconstructioninprogresscurrent": 2618000,
    "accrueddeferredexpensesassociatedwithfinancingactivitiescurrent": 96000,
    "accruedprofessionalfeescurrent": 1150000,
    "otheraccrualsandothercurrentliabilities": 273000,
    "accountspayableandotheraccruedliabilitiescurrent": 22519000,
    "otherlongtermdebt": 236000,
    "lossonfairvalueremeasurementofequitycommitment": 3530000,
    "gainonfairvalueremeasurementofsharepurchaseoption": 260000,
    "othernonoperatingincomeexpenseother": -4000,
    "operatingleasecost": 6132000,
    "leasecost": 6132000,
    "operatingleasepayments": 6044000,
    "operatingleaseweightedaverageremainingleaseterm1": "P9Y2M1D",
    "operatingleaseweightedaveragediscountratepercent": 0.099,
    "shorttermleasecost": 1500000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 5737000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 5918000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 6096000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 6289000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 6457000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 29084000,
    "lesseeoperatingleaseliabilitypaymentsdue": 59581000,
    "lesseeoperatingleasetenantimprovementallowancereceivable": 5595000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 20981000,
    "operatingleaseliability": 33005000,
    "operatingleaseassets": 24459000,
    "warrantsandrightsoutstandingterm": "P5Y",
    "allocatedsharebasedcompensationexpense": 10521000,
    "stockoptionawardexercisepriceaspercentageoffairmarketvalue": 1,
    "stockoptionplanterm": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardmaximumavailablevestingamountdescription": "The Available Vesting Amount was equal to the number of shares subject to the stock option multiplied by an equity ratio of total capital received from investors (up to a maximum of $350.0 million) divided by $350.0 million",
    "percentageoffullydilutedshares": 0.1,
    "capitalunitsnetamount": 350000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 12464668,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrights": "Restricted stock unit awards granted under the Plan generally vest in three equal annual installments beginning on the first anniversary of the vesting start date.",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightsremainingpercentage": 0.75,
    "shareoptionsgrantedinstallments": "three equal annual installments",
    "numberofinstallmentsofshareoptionsgranted": 36,
    "closingpriceofcommonstock": 16.58,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 6.12,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 100000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P1Y2M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 100000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0076,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y1M17D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.991,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiod": 3370353,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 236057,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionscanceledduetoachievementofperformancecondition": 4930968,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 4250006,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 6.37,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 9.92,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 6.8,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionscanceledduetoachievementofperformanceconditionweightedaverageexerciseprice": 5.4,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 5.2,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P8Y6M25D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P8Y2M4D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 127301000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 48377000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 71350,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 42810,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 2.02,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 1.97,
    "preferredstockredemptionpremium": 3871000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 17685665,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationtaxsettlementsstateandlocal": 0.057,
    "effectiveincometaxratereconciliationexecutivecompensation": 0.011,
    "effectiveincometaxratereconciliationnondeductibleexpensefairvalueadjustment": 0.005,
    "effectiveincometaxratereconciliationtaxcredits": 0.026,
    "effectiveincometaxratereconciliationotheradjustments": 0.002,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.279,
    "deferredtaxassetsoperatinglosscarryforwards": 57949000,
    "deferredtaxassetoperatingleaseliabilities": 8895000,
    "deferredtaxassetstaxcreditcarryforwards": 6217000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 2983000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 2361000,
    "deferredtaxassetamortization": 736000,
    "deferredtaxassetsgross": 79141000,
    "deferredtaxassetsvaluationallowance": 68970000,
    "deferredtaxassetsnet": 10171000,
    "deferredtaxliabilitiesdepreciation": 1772000,
    "deferredtaxliabilitiesleasingarrangements": 6592000,
    "deferredtaxliabilitiesprepaidexpenses": 1809000,
    "deferredincometaxliabilities": 10173000,
    "deferredtaxliabilities": 2000,
    "valuationallowancedeferredtaxassetchangeinamount": 42500000,
    "deferredtaxassetsoperatinglosscarryforwardsnotsubjecttoexpiration": 213900000,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 206200000,
    "taxcreditcarryforwardamount": 700000,
    "taxcreditcarryforwardexpirationyear": 2035,
    "currentstateandlocaltaxexpensebenefit": 2000,
    "deferredfederalincometaxexpensebenefit": -26000,
    "definedcontributionplanadministrativeexpenses": 1400000,
    "numberofmembersappointedtoboardofdirectors": 4,
    "relatedpartytransactionperiodicpaymentamount": 1000000,
    "managementfeeexpense": 3800000
  }
]